Abstracts tagged "Economics and gout"

Abstract Number: 2241 • 2016 ACR/ARHP Annual Meeting
Health Economics of Uncontrolled Gout in the United States: A Systematic Literature Review
Shaum Kabadi¹, Julie Myers², Christopher Bly², Ron Wielage² and Robert Morlock³, ¹AstraZeneca, Gaithersburg, MD, ²Medical Decision Modeling Inc., Indianapolis, IN, ³Ardea Biosciences, Inc., San Diego, CA
Background/Purpose: Gout is a crystal deposition disease and the most prevalent inflammatory arthritis in the United States (US). Maintaining gout control has been associated with…
Abstract Number: 1155 • 2014 ACR/ARHP Annual Meeting
Economic Impact of Frequent Gout Flares in a Managed Care Setting
Robert Jackson¹, Aki Shiozawa², Erin Buysman³, Aylin Altan³, Stephanie Korrer³ and Hyon K. Choi⁴, ¹Global Medical Office, Takeda Pharmaceuticals International, Inc, Deerfield, IL, ²One Takeda Parkway, Takeda Pharmaceuticals International, Inc, Deerfield, IL, ³Health Economics and Outcomes Research, Optum, Eden Prairie, MN, ⁴Boston University School of Medicine, Boston, MA
Background/Purpose Gout is the most common inflammatory arthritis in the US. For most patients, excruciatingly painful gout attacks (“flares”) are the major clinical burden of…
Abstract Number: 211 • 2013 ACR/ARHP Annual Meeting
The Economic Burden Of Gout: A Systematic Review Of Direct and Indirect Costs
Sharan Rai¹, Aliya Haji², Lindsay C Burns³ and Hyon Choi^4,5, ¹Arthritis Research Centre of Canada, Richmond, BC, Canada, ²Research, Arthritis Research Centre of Canada, Richmond, BC, Canada, ³Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada, ⁴Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, ⁵Division of Rheumatology, Allergy, and Immunology Massachusetts General Hospital, Harvard Medical School, Boston, MA
Background/Purpose: The prevalence of gout, an excruciating and disabling joint disease, has been increasing in recent decades such that it now constitutes the most…